Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label OVA1. Show all posts
Showing posts with label OVA1. Show all posts
Wednesday, May 16, 2012

paywalled: Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.

›
Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. : ABSTRACT: More than 200,000 women undergo explo...
Monday, May 14, 2012

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers (OVA1)

›
An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers Dr. Zhang is the ...
Monday, April 16, 2012

press release: (OVA1) Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer

›
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer (press release) About OVA1 ...
Wednesday, March 07, 2012

AMA Approves Vermillion MAAA Category 1 Code for OVA1; Will it Improve Reimbursement? GenomeWeb (Medicare)

›
"Medicare reimbursement has been a point of concern for the company. As previously covered in PGx Reporter sister publication ProteoMo...
Thursday, February 23, 2012

(OVA1) Vermillion Reports Preliminary Fourth Quarter and Full Year 2011 Results - business news

›
Wednesday, February 22, 2012

abstract: Risk of Malignancy in Sonographically Confirmed Ovarian Tumors

›
Abstract Ovarian cancer is the leading cause of gynecologic cancer death in the United States. Once an ovarian tumor is identified, a...
Thursday, January 05, 2012

Vermillion plans to reduce headcount, expenses - financial news (OVA1)

›
Vermillion Inc. VRML -2.76% ...
Tuesday, May 24, 2011

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment - press release - 2nd study

›
Second study in Obstetrics & Gynecology showcases OVA1's role in evaluating women with an ovarian mass  " In the manuscript ...
Saturday, April 23, 2011

press release- (OVA1 test) Vermillion to Host Conference Call to Present Company Update and Review Financial Results May 10th, 2011

›
Wednesday, March 09, 2011

financial news: Healthcare Stock on Watch; Vermillion (OVA1) climbs on Poster Presentation | Beacon Equity: Penny Stocks, Stock Alerts

›
Healthcare Stock on Watch; Vermillion climbs on Poster Presentation Posted by g.zalesak on Mar 08, 2011 Vermillion Inc. ( NASDAQ: VRML ) ...
Monday, March 07, 2011

(OVA1) Vermillion Attends 42nd Annual Meeting of the SGO March 7, 2011 /PRNewswire/ --

›
Note: see press release for more details " OVA1 improves the sensitivity of the ACOG referral guidelines for an ovarian mass" ...
Tuesday, November 16, 2010

(OVA1 ovarian cancer blood test) Vermillion Inks New Agreement with Quest Diagnostics - GLG News

›
Friday, August 20, 2010

In research - Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial ProteoMonitor GenomeWeb

›
........"In ovarian cancer, the single protein that's commonly used [as a biomarker], CA-125, is not a very accurate test ," ...
Wednesday, August 18, 2010

Vermillion's OVA1 2010 Sales Target Is Looking Like a Moon Shot. How Will it Hit It? GenomeWeb (financial)

›
The test, approved last September , costs $650 and is reimbursed at $540 by Medicare, according to the company. ( assuming U.S. dollars )
Friday, July 23, 2010

OVA1 - Vermillion Announces Relocation of Corporate Offices to Austin, Texas - MarketWatch

›
Tuesday, July 06, 2010

Vermillion Announces Relisting on NASDAQ - re: OVA1 ovarian diagnositic test (financial news)

›
Thursday, May 27, 2010

For Vermillion, a Likely Off-Label Play for OVA1 as OVA2 Gains R&D Traction GenomeWeb

›
Note : financial news
Monday, May 10, 2010

Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments - financial news

›
Note: in prior new/press releases the Arrayit testing is still seeking FDA (U.S.) approval, this is not the same test as OVA1 which is the ...
Friday, March 26, 2010

Arrayit Signs on Docro to Help Ovarian Cancer Diagnostic Gain FDA Clearance GenomeWeb

›
Vermillion's OVA1 became the first protein-based in vitro diagnostic multivariate index assay to receive FDA clearance [See PM 09/1...
Monday, March 22, 2010

Medical News: SGO: Test Aids Preop Decisions About Ovarian Masses - in Meeting Coverage, SGO - OVA1

›
"...However, the test's low specificity raised some concern, as verbalized by an invited discussant of the study." MedPage To...